Delivery Order SPE2DB20D3303-SPE2DB24FA3HE
Award Date
9/20/24
Potential Completion Date
9/23/24
Potential Value
$33K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XELJANZ XR 11 MG TABLET. The contract has a ceiling value of $13,506.67 and a completion date of May 30, 2025. The award is not set-aside and represents an individual delivery order under AmerisourceBergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XELJANZ XR 11 MG TABLET UU 30S. The contract has a ceiling value of $1,669.99 and a performance period through March 11, 2025. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of XELJANZ XR 11 MG TABLET. The award has a ceiling value of $33,058.46 and will run through August 9, 2024. The contract is a firm-fixed price delivery order, with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply a wide range of prescription medications, medical supplies, and equipment to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XELJANZ XR 11 MG TABLET, a prescription medication. The firm-fixed-price delivery order, valued at $22,912.52, has an ultimate completion date of August 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of XELJANZ XR 11 MG TABLET, a prescription medication. The contract has a ceiling value of $68,267.89 and is set to expire on September 10, 2024. This award is a firm-fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. The IDC enables DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of XELJANZ XR 11 MG TABLET. The fixed-price delivery order, valued at $39,710.32, has a completion date of September 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these prescription medications to support DLA's medical supply requirements. This order is issued under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of XELJANZ XR 11 MG TABLET. The award has a firm fixed price ceiling value of $5,901.13 and an ultimate completion date of August 30, 2024. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of XELJANZ XR 11 MG TABLET (30-count) for $10,570.55. The contract has a firm fixed price and an ultimate completion date of August 26, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of its Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of XELJANZ XR 11 MG TABLET, a prescription medication. The firm-fixed-price contract has a ceiling value of $54,264.60 and a period of performance through September 9, 2024. AmerisourceBergen, a major pharmaceutical distributor, is delivering these pharmaceutical products to support military treatment programs and other federal healthcare facilities. This order is part of a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of XELJANZ XR 11 MG TABLET. The firm-fixed-price contract has a ceiling value of $27,129.78 and an ultimate completion date of August 23, 2024. The contract is not set aside for any specific business type. This delivery order is a part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support...